Entyr Stock Quote ETR - Stock Price, News, Charts, Message Board, Trades

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
Australia
ASX
Entyr Ltd (ETR) Quote

Entyr Ltd (ETR)

0.007

0.00

(0.00%)

Closed April 29 2:00AM

Delayed by 20 minutes

Unlock more advanced trading tools

Join ADVFN today

Current Price

0.007

Bid

0.008

Ask

0.007

Volume

0.00

0.00 Day's Range 0.00

0.006 52 Week Range 0.025

Market Cap

Previous Close

0.007

Open

-

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

1,338,113

Shares Outstanding

1,983,103,893

Dividend Yield

-

PE Ratio

-1.96

Earnings Per Share (EPS)

-0.01

Revenue

13.55M

Net Profit

-10.18M

Sector

Gold Ores

Industry

Gold Ores

Website

www.pearlglobal.com.au

Headquarters

Perth, Western Australia, Aus

Founded

1970

Entyr Ltd is listed in the Gold Ores sector of the Australian Stock Exchange with ticker ETR. The last closing price for Entyr was AUD0.01. Over the last year, Entyr shares have traded in a share price range of AUD 0.006 to AUD 0.025.

Entyr currently has 1,983,103,893 shares outstanding. The market capitalization of Entyr is AUD19.83 million. Entyr has a price to earnings ratio (PE ratio) of -1.96.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	-0.004	-36.3636363636	0.011	0.013	0.007	1338113	0.01050451	DE
26	0.001	16.6666666667	0.006	0.022	0.006	2605637	0.01266637	DE
52	-0.017	-70.8333333333	0.024	0.025	0.006	2528486	0.01183161	DE
156	-0.008	-53.3333333333	0.015	0.031	0.006	2363006	0.01443765	DE
260	-0.008	-53.3333333333	0.015	0.031	0.006	2363006	0.01443765	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DCPHDeciphera Pharmaceuticals Inc	$ 25.04 (70.92%)	16.76M
CAUDCollective Audience Inc	$ 0.55 (41.03%)	1.17M
INHDInno Holdings Inc	$ 0.88 (39.57%)	11.71M
CSPICSP Inc	$ 18.46 (36.44%)	39
SRZNSurrozen Inc	$ 12.00 (33.63%)	11
CLVRClever Leaves Holdings Inc	$ 1.52 (-63.02%)	143.86k
MRXMarex Group PLC	$ 7.60 (-60.00%)	1.04k
ADXNAddex Therapeutics Ltd	$ 7.67 (-52.36%)	24.31k
TSLZT Rex 2X Inverse Tesla Daily Target ETF	$ 29.47 (-24.96%)	1.13M
TSDDGraniteShares ETF Trust GraniteShares	$ 18.70 (-24.90%)	188.73k
AKANAkanda Corporation	$ 0.1312 (27.38%)	22.38M
DCPHDeciphera Pharmaceuticals Inc	$ 25.04 (70.92%)	16.76M
ARQQArqit Quantum Inc	$ 0.5845 (19.85%)	15.44M
SOFISoFi Technologies Inc	$ 7.64 (-2.92%)	14.72M
PEGYPineapple Energy Inc	$ 0.0649 (3.67%)	13.1M

sloppyjones

sloppyjones 2 minutes ago

Agreed. Looks like they are scrambling and updating as they go (just a place holder), but yes, the link should be to the video or some other landing page for sure.

The other link was the 2 boxers being interviewed by fox news. It was about the event, not vume.

Just w

Diogenes of Sinope

Diogenes of Sinope 3 minutes ago

'Donald Trump is incapable of running anything': Union slams Trump in new ad

https://youtu.be/iukr0Nj_sAs?si=cWPqJIrucu07rhuX

joe botts

joe botts 3 minutes ago

Because it's revoked, has been revoked for years and will still be revoked May 7...You come back and see... Tell you what come back May 8th.It will still be revoked..

stocksrising

stocksrising 4 minutes ago

More consolidation in Oncology:

Deciphera Pharmaceuticals to Be Acquired by ONO Pharmaceutical in $2.4 Billion Deal
MT Newswires 07:29AM ET, 04/29/2024
07:29 AM EDT, 04/29/2024 (MT
Newswires) -- Deciphera
Pharmaceuticals (DCPH) said Monday it has en

abrooklyn

abrooklyn 4 minutes ago

ARAX HOLDINGS CORP
FORM 10-K
(Annual Report)
Filed 04/26/24 for the Period Ending 10/31/23

https://www.otcmarkets.com/filing/conv_pdf?id=17483354&guid=25Q-keBRfG8WJth

al44

al44 4 minutes ago

It's the Economy... Again

By Victoria White Berger

Biden continues to lie about the economic circumstances of our country, and we have no reason to believe he will change:

By this November 5, a high electoral price from the Democrats may be called in due

georgie18

georgie18 4 minutes ago

IFBD...$5.17...in the P/M...Off my $4.90 Alert...🥳

georgie18

Member Level
Re: None

Sunday, April 28, 2024 9:54:41 AM

Post#
641497
of 641518
IFBD...$4.90... https://schrts.co/SWBNfNCR ...🥳... "W

Katfish

Katfish 4 minutes ago

NKGN - 1.90/1.91 Up from 1.61

NKGen Biotech Announces FDA Clearance Of IND Application For SNK01 NK Cell Therapy in Parkinson's Disease

georgie18

georgie18 4 minutes ago

IFBD...$5.17...in the P/M...Off my $4.90 Alert...🥳

georgie18

Member Level
Re: None

Sunday, April 28, 2024 9:54:41 AM

Post#
641497
of 641518
IFBD...$4.90... https://schrts.co/SWBNfNCR ...🥳... "W

Uncle Monkey

Uncle Monkey 5 minutes ago

great call!!! hahah

WALLnut

WALLnut 5 minutes ago

IronChefQuezon

IronChefQuezon 5 minutes ago

He knows. He used to take money to pump trash tickers. Now he just lives here for whatever reason.

ziploc_1

ziploc_1 5 minutes ago

CAPT... When the FDA, in 2019, approved Vascepa for treating patients for the CVD indication, the approval, at that time, was....ONLY for patients with TG's of 150 mgs/dcl or more...(plus diabetes or other risk factors for CVD).

Amarin now needs to contact the FDA about this NEW in

Atlanta1

Atlanta1 5 minutes ago

$22 sure looks like a good time to buy.....

$FL

Golden Cross

Golden Cross 5 minutes ago

💲🛫💯$AGBA This area looks to be a good loading zone

AlwaysOptimistic

AlwaysOptimistic 6 minutes ago

Please stop. Talk about the investment not other people. Simple IHUB TOS rule former Moderator.

trader_ron

trader_ron 6 minutes ago

$RTON News- Right on Brands Announces Major Product Line Expansion via HONEY® Brands ( 13 stores with 12 more in 2024)

https://www.otcmarkets.com/stock/RTON/news/story?e&id=2826999

trader_ron

trader_ron 6 minutes ago

$RTON News- Right on Brands Announces Major Product Line Expansion via HONEY® Brands ( 13 stores with 12 more in 2024)

https://www.otcmarkets.com/stock/RTON/news/story?e&id=2826999

jeunke22

jeunke22 6 minutes ago

Hope you guys noticed that the LWLG investor slide deck mentioned 'research analysts' visiting the OFC live demonstrations. In Belgium Michael Lebby told us that these analysts have been following Lightwave seriously since last year's OFC. Analyst attendance kind of neutralizes the argument, often m

learningcurve2020

learningcurve2020 6 minutes ago

...And, that's the other point; A trial going four years beyond its original design while waiting for some tiny survival curve to mature, who knows what other treatments those longer lived patients were on maybe without even Bosch's knowledge??

Golden Cross

Golden Cross 6 minutes ago

This area looks to be a good loading zone

stockgringo

stockgringo 6 minutes ago

https://healthstockshub.com/news/nasdaq/jagx/napo-pharmaceuticals-a-jaguar-health-family-company-sponsoring-pediatric-gastroenterology-conference-in-abu-dhabi-and-panel-discussion-about-microvillus-inclusion-disease-mvid

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions